A detailed history of Evolution Advisers, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Evolution Advisers, Inc. holds 48 shares of PFE stock, worth $1,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Holding current value
$1,269
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$24.8 - $30.19 $1,190 - $1,449
48 New
48 $1,000
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $27,450 - $34,014
600 Added 309.28%
794 $41,000
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $8,016 - $11,882
194 New
194 $11,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Evolution Advisers, Inc. Portfolio

Follow Evolution Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Evolution Advisers, Inc. with notifications on news.